Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Bartoletti

Showing results (21-30 of 209) with videos related to

Pageof 21
Sort By:
Antibiotics (Basel, Switzerland)|April 28, 2023
Impact of Inflammation on Voriconazole Exposure in Critically ill Patients Affected by Probable COVID-19-Associated Pulmonary AspergillosisMilo Gatti, Giacomo Fornaro, Zeno Pasquini, et al.
International Journal of Molecular Sciences|July 13, 2019
Platinum Salts in Patients with Breast Cancer: A Focus on Predictive FactorsMattia Garutti, Giacomo Pelizzari, Michele Bartoletti, et al.
Microorganisms|August 28, 2025
COVID-19 Vaccination Still Makes Sense: Insights on Pneumonia Risk and Hospitalization from a Large-Scale Study at an Academic Tertiary Center in ItalyElena Azzolini, Brenda Lupo Pasinetti, Antonio Voza, et al.
Cancers|July 2, 2021
Inhibition of CDK4/6 as Therapeutic Approach for Ovarian Cancer Patients: Current Evidences and Future PerspectivesAlessandra Dall'Acqua, Michele Bartoletti, Nastaran Masoudi-Khoram, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|July 26, 2021
Cell-stiffness and morphological architectural patterns in clinical samples of high grade serous ovarian cancersEros Azzalini, Nodira Abdurakhmanova, Pietro Parisse, et al.
The Journal of Antimicrobial Chemotherapy|April 4, 2022
Dynamic evolution of imipenem/relebactam resistance in a KPC-producing Klebsiella pneumoniae from a single patient during ceftazidime/avibactam-based treatmentsPaolo Gaibani, Federica Bovo, Linda Bussini, et al.
Microorganisms|April 23, 2022
Successful Treatment of Bloodstream Infection due to a KPC-Producing Klebsiella Pneumoniae Resistant to Imipenem/Relebactam in a Hematological PatientPaolo Gaibani, Linda Bussini, Stefano Amadesi, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 30, 2023
Colonization by ceftazidime/avibactam-resistant KPC-producing Klebsiella pneumoniae following therapy in critically ill patientsPaolo Gaibani, Federica Bovo, Linda Bussini, et al.
Journal of Global Antimicrobial Resistance|October 28, 2021
A descriptive case series of pharmacokinetic/pharmacodynamic target attainment and microbiological outcome in critically ill patients with documented severe extensively drug-resistant Acinetobacter baumannii bloodstream infection and/or ventilator-associated pneumonia treated with cefiderocolMilo Gatti, Michele Bartoletti, Pier Giorgio Cojutti, et al.
Clinical Breast Cancer|March 30, 2023
Mild Cryotherapy for Prevention of Paclitaxel-Induced Nail Toxicity in Breast Cancer Patients: A Phase II Single-Arm Clinical TrialCristina Mazzega-Fabbro, Jerry Polesel, Simon Spazzapan, et al.
Pageof 21

Showing results (21-30 of 209) with videos related to

Sort By:
Pageof 21
Antibiotics (Basel, Switzerland)|April 28, 2023
Impact of Inflammation on Voriconazole Exposure in Critically ill Patients Affected by Probable COVID-19-Associated Pulmonary AspergillosisMilo Gatti, Giacomo Fornaro, Zeno Pasquini, et al.
International Journal of Molecular Sciences|July 13, 2019
Platinum Salts in Patients with Breast Cancer: A Focus on Predictive FactorsMattia Garutti, Giacomo Pelizzari, Michele Bartoletti, et al.
Microorganisms|August 28, 2025
COVID-19 Vaccination Still Makes Sense: Insights on Pneumonia Risk and Hospitalization from a Large-Scale Study at an Academic Tertiary Center in ItalyElena Azzolini, Brenda Lupo Pasinetti, Antonio Voza, et al.
Cancers|July 2, 2021
Inhibition of CDK4/6 as Therapeutic Approach for Ovarian Cancer Patients: Current Evidences and Future PerspectivesAlessandra Dall'Acqua, Michele Bartoletti, Nastaran Masoudi-Khoram, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|July 26, 2021
Cell-stiffness and morphological architectural patterns in clinical samples of high grade serous ovarian cancersEros Azzalini, Nodira Abdurakhmanova, Pietro Parisse, et al.
The Journal of Antimicrobial Chemotherapy|April 4, 2022
Dynamic evolution of imipenem/relebactam resistance in a KPC-producing Klebsiella pneumoniae from a single patient during ceftazidime/avibactam-based treatmentsPaolo Gaibani, Federica Bovo, Linda Bussini, et al.
Microorganisms|April 23, 2022
Successful Treatment of Bloodstream Infection due to a KPC-Producing Klebsiella Pneumoniae Resistant to Imipenem/Relebactam in a Hematological PatientPaolo Gaibani, Linda Bussini, Stefano Amadesi, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 30, 2023
Colonization by ceftazidime/avibactam-resistant KPC-producing Klebsiella pneumoniae following therapy in critically ill patientsPaolo Gaibani, Federica Bovo, Linda Bussini, et al.
Journal of Global Antimicrobial Resistance|October 28, 2021
A descriptive case series of pharmacokinetic/pharmacodynamic target attainment and microbiological outcome in critically ill patients with documented severe extensively drug-resistant Acinetobacter baumannii bloodstream infection and/or ventilator-associated pneumonia treated with cefiderocolMilo Gatti, Michele Bartoletti, Pier Giorgio Cojutti, et al.
Clinical Breast Cancer|March 30, 2023
Mild Cryotherapy for Prevention of Paclitaxel-Induced Nail Toxicity in Breast Cancer Patients: A Phase II Single-Arm Clinical TrialCristina Mazzega-Fabbro, Jerry Polesel, Simon Spazzapan, et al.
Pageof 21